Ortho C+ (Formerly known as TLC 3.0)
High-dose vitamin C & electrolyte formula
- Increases collagen synthesis
- Promotes healthy blood vessels
- Based on Linus Pauling’s research on high-dose vitamin C
$29.96 — or subscribe and save 20%
Out of stock
AOR’s Ortho C+ provides proper doses of the nutrients necessary for helping maintain and support cardiovascular health. Ortho C+ represents a true orthomolecular formulation with testimonials that indicate amazing results.
Maintaining heart health is imperative for a long, healthy life. Although the steps to achieve heart health are relatively simple, the western lifestyle makes it difficult for the majority of adults to stay on track. Physical activity, balanced nutrition, and low levels of stress all help maintain a healthy heart. The right supplement can also help support cardiovascular health.
Medicinal research over time has led to the development of a wide variety of supplements. In 1992, research conducted by Linus Pauling and Matthias Rath lead to a revolutionary discovery showing the inverse relationship between the internal production of lipoprotein (a) and vitamin C. Rath described it as the scurvy-heart disease connection. They stated that Lp(a) can act as a surrogate for vitamin C and protect the integrity of the blood vessels in times that the human body is experiencing a vitamin C deficiency, which may develop into scurvy.
AOR’s Ortho C+ contains an unprecedented combination of nutrients to keep blood vessels strong and support arterial health. Ortho C+ is ideal for those looking for a high-dose vitamin C formula or electrolyte formula, or for those who are concerned about their cardiovascular health.
Ortho C+ is formulated based on the research of Linus Pauling and Matthias Rath on lipoprotein(a) [Lp(a)]. Ortho C+ contains vitamin C, calcium, and magnesium.*
AOR™ guarantees that all ingredients have been included on the label. Made without wheat, gluten, dairy, soy, eggs or shellfish.
Stir one level tablespoon (11.5 g) into a glass of water or juice once daily, or as directed by a qualified health care practitioner.
Consult a health care practitioner before use if you’re pregnant, lactating, have a medical condition, or if you’re taking any medication. Keep out of reach of children.
- Arterial support
- Cardiovascular support
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
† Daily Value not established.
Other Ingredients: silicon dioxide, natural lemon flavor (maltodextrin, dextrose, acacia gum and tricalcium phosphate) and propylene glycol.
Boonmark NW, Lou XJ, Yang ZJ, Schwartz K, Zhang JL, Rubin EM, Lawn RM. Modification of apolipoprotein(a) lysine binding site reduces atherosclerosis in transgenic mice. J Clin Invest. 1997 Aug 1;100(3):558-64.
Lippi G, Guidi G. Lipoprotein(a): an emerging cardiovascular risk factor. Crit Rev Clin Lab Sci. 2003 Feb; 40(1): 1-42.
Price KD, Price CS, Reynolds RD. Hyperglycemia-induced latent scurvy and atherosclerosis: the scorbutic-metaplasia hypothesis. Med Hypotheses. 1996 Feb; 46(2): 119-29.
Rath M. and Pauling L. Immunological evidence for the accumulation of lipoprotein(a) in the atherosclerotic lesion of the hypoascorbemic guinea pig. PNAS. 87(23): 9388-90. Rath M, Pauling L. Hypothesis: lipoprotein(a) is a surrogate for ascorbate. PNAS. 1990 Aug; 87(16): 6204-7.
Rath M. Lipoprotein(a) reduction by ascorbate. J Orthomolec Med. 1992 Aug; 7(1): 81-2.
Rath M. Reducing the risk for cardiovascular disease with nutritional supplements. J Orthomolec Med.1995; 7(3): 153-62.
Trieu VN, Zioncheck TF, Lawn RM, McConathy WJ. Interaction of apolipoprotein(a) with apolipoprotein B-containing lipoproteins. J Biol Chem. 1991 Mar 25; 266(9): 5480-5.
Willis GC. The reversibility of atherosclerosis. CMAJ. 1957 Jul 15; 77(2): 106-9.